Ras-mutant Cancer Cells Display B-Raf Binding to Ras That Activates Extracellular Signal-regulated Kinase and Is Inhibited by Protein Kinase A Phosphorylation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ras-mutant Cancer Cells Display B-Raf Binding to Ras That Activates Extracellular Signal-regulated Kinase and Is Inhibited by Protein Kinase A Phosphorylation
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 38, Pages 27646-27657
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-07-27
DOI
10.1074/jbc.m113.463067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells
- (2013) Tara J. Dillon et al. INTERNATIONAL IMMUNOLOGY
- Rapgef2 Connects GPCR-Mediated cAMP Signals to ERK Activation in Neuronal and Endocrine Cells
- (2013) A. C. Emery et al. Science Signaling
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferationin Vivo
- (2012) Adam J. Linley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RAF Inhibitor-Induced KSR1/B-RAF Binding and Its Effects on ERK Cascade Signaling
- (2011) Melissa M. McKay et al. CURRENT BIOLOGY
- Cancer therapy based on oncogene addiction
- (2011) Frank McCormick JOURNAL OF SURGICAL ONCOLOGY
- ERK and PDE4 cooperate to induce RAF isoform switching in melanoma
- (2011) Amélie Marquette et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting the RAS pathway in melanoma
- (2011) Zhenyu Ji et al. TRENDS IN MOLECULAR MEDICINE
- RAF protein-serine/threonine kinases: Structure and regulation
- (2010) Robert Roskoski BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pin1 expression contributes to lung cancer prognosis and carcinogenesis
- (2010) Xiaogang Tan et al. CANCER BIOLOGY & THERAPY
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Oncogenic K-ras “addiction” and synthetic lethality
- (2010) Anurag Singh et al. CELL CYCLE
- The Interaction of Epac1 and Ran Promotes Rap1 Activation at the Nuclear Envelope
- (2010) C. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade
- (2010) F. Donelson Smith et al. NATURE CELL BIOLOGY
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades
- (2009) Jun Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades
- (2009) Uma Kant Misra et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
- (2009) D. A. Ritt et al. MOLECULAR AND CELLULAR BIOLOGY
- Protein Kinase A and B-Raf Mediate Extracellular Signal-Regulated Kinase Activation by Thyrotropin
- (2009) L. A. Vuchak et al. MOLECULAR PHARMACOLOGY
- Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
- (2009) Bijay S. Jaiswal et al. PLoS One
- Ras Is Required for the Cyclic AMP-Dependent Activation of Rap1 via Epac2
- (2008) C. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started